| Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult … VIPTS Group1A American journal of ophthalmology 131 (5), 541-560, 2001 | 1027* | 2001 |
| Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. NM Bressler Archives of ophthalmology (Chicago, Ill.: 1960) 119 (2), 198-207, 2001 | 910 | 2001 |
| Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) U Schmidt-Erfurth, V Chong, A Loewenstein, M Larsen, E Souied, ... British Journal of Ophthalmology 98 (9), 1144-1167, 2014 | 620 | 2014 |
| Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3 SR Sadda, R Guymer, FG Holz, S Schmitz-Valckenberg, CA Curcio, ... Ophthalmology 125 (4), 537-548, 2018 | 598 | 2018 |
| Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group RF Spaide, GJ Jaffe, D Sarraf, KB Freund, SR Sadda, G Staurenghi, ... Ophthalmology 127 (5), 616-636, 2020 | 531 | 2020 |
| Prevalence of age-related macular degeneration in Europe: the past and the future JM Colijn, GHS Buitendijk, E Prokofyeva, D Alves, ML Cachulo, ... Ophthalmology 124 (12), 1753-1763, 2017 | 515 | 2017 |
| Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin-1-year results of a randomized clinical trial-VIP report no. 1 J Arnold, D Kilmartin, J Olson, S Neville, K Robinson, A Laird, ... Ophthalmology 108 (5), 841-852, 2001 | 426 | 2001 |
| Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. KJ Blinder, MS Blumenkranz, NM Bressler, SB Bressler, G Donato, ... Ophthalmology 110 (4), 667-673, 2003 | 414 | 2003 |
| C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial GJ Jaffe, K Westby, KG Csaky, J Monés, JA Pearlman, SS Patel, ... Ophthalmology 128 (4), 576-586, 2021 | 322 | 2021 |
| Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical … Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP ... Archives of ophthalmology 120 (10), 1307-1314, 2002 | 311* | 2002 |
| Treat-and-extend regimens with anti-VEGF agents in retinal diseases: a literature review and consensus recommendations KB Freund, JF Korobelnik, R Devenyi, C Framme, J Galic, E Herbert, ... Retina 35 (8), 1489-1506, 2015 | 278 | 2015 |
| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 261 | 2022 |
| Risk of inflammation, retinal vasculitis, and retinal occlusion–related events with brolucizumab: post hoc review of HAWK and HARRIER J Monés, SK Srivastava, GJ Jaffe, R Tadayoni, TA Albini, PK Kaiser, ... Ophthalmology 128 (7), 1050-1059, 2021 | 260 | 2021 |
| Treat-and-extend versus monthly regimen in neovascular age-related macular degeneration: results with ranibizumab from the TREND study R Silva, A Berta, M Larsen, W Macfadden, C Feller, J Monés, ... Ophthalmology 125 (1), 57-65, 2018 | 241 | 2018 |
| Digital indocyanine-green angilography in chorioretinal disorders DR Guyer, CA Puliafito, JM Monés, E Friedman, W Chang, SR Verdooner Ophthalmology 99 (2), 287-291, 1992 | 220 | 1992 |
| Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study G Soubrane, A Cruess, A Lotery, D Pauleikhoff, J Monès, X Xu, G Zlateva, ... Archives of ophthalmology 125 (9), 1249-1254, 2007 | 218 | 2007 |
| Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4 RH Guymer, PJ Rosenfeld, CA Curcio, FG Holz, G Staurenghi, KB Freund, ... Ophthalmology 127 (3), 394-409, 2020 | 209 | 2020 |
| Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from classification of atrophy consensus meetings FG Holz, SVR Sadda, G Staurenghi, M Lindner, AC Bird, BA Blodi, ... Ophthalmology 124 (4), 464-478, 2017 | 207 | 2017 |
| Management of retinal vein occlusion–consensus document G Coscas, A Loewenstein, A Augustin, F Bandello, M Battaglia Parodi, ... Ophthalmologica 226 (1), 4-28, 2011 | 184 | 2011 |
| Dual antagonism of PDGF and VEGF in neovascular age-related macular degeneration: a phase IIb, multicenter, randomized controlled trial GJ Jaffe, TA Ciulla, AP Ciardella, F Devin, PU Dugel, CM Eandi, ... Ophthalmology 124 (2), 224-234, 2017 | 145 | 2017 |
